Actively Recruiting
Assessing the Accuracy of the Dexcom G7 Continuous Glucose Monitor in Adults in Intensive Care After Major Abdominal Surgery or Organ Transplant
Led by Institute for Clinical and Experimental Medicine · Updated on 2026-05-28
62
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the accuracy of the Dexcom G7 Continuous Glucose Monitoring CGM system in critically ill patients who are undergoing major abdominal surgeries or solid organ transplantation in the intensive care unit ICU. The study focuses on patients who require blood glucose monitoring for insulin therapy and aims to determine how well the CGM system measures glucose levels compared to standard blood glucose meters. The study also aims to assess the devices ability to detect low and high blood sugar events and to identify factors that affect its accuracy in this ICU setting. Each patient in the ICU will wear two Dexcom G7 sensors placed in the infraclavicular position one sensor will be blinded and inactive for glucose monitoring, while the other will actively monitor glucose levels and can be used to adjust insulin doses. Calibration of the active sensor is performed using blood glucose meter readings at specified intervals during the first three days and as needed thereafter. Patients will wear the sensors for up to 10 days, covering their stay in the ICU and immediate care unit, with no interference in standard clinical care. Participants will have glucose measurements taken four times a day for up to six days, along with daily recording of their Sequential Organ Failure Assessment SOFA score. Researchers will calculate the mean absolute relative difference MARD between the calibrated and non-calibrated sensors as the primary outcome. Additional accuracy metrics, sensor performance data, and safety will also be monitored throughout the study period, which lasts until ICU discharge or up to 10 days.
CONDITIONS
Brief Title
Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.
Research Team
M
Marek Protus, MD
A
Alexander Macek, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here